Back to AZN
Cambridge Investment Research Advisors, Inc. → AZN
Cambridge Investment Research Advisors, Inc. AZN Position History
AstraZeneca PLC • Healthcare
Quarters held
7
Latest value
$11.8M
Q3 2026
Peak value
$13M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $9.4M |
| Q4 2025 | $11.7M |
| Q1 2026 | $12.9M |
| Q2 2026 | $13M |
| Q2 2026 | $13M |
| Q3 2026 | $279K |
| Q3 2026 | $11.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $11.8M | 72.7K | — | — |
| Q3 2026 | $279K | 6.3K | — | — |
| Q2 2026 | $13M | 69.0K | — | — |
| Q2 2026 | $13M | 69.0K | — | — |
| Q1 2026 | $12.9M | 66.1K | — | — |
| Q4 2025 | $11.7M | 127.0K | — | — |
| Q3 2025 | $9.4M | 123.0K | — | — |